Prosight Management’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-444,068
Closed -$1.31M 40
2018
Q3
$1.31M Buy
444,068
+249,405
+128% +$738K 0.73% 27
2018
Q2
$716K Sell
194,663
-38,340
-16% -$141K 0.52% 27
2018
Q1
$816K Sell
233,003
-63,485
-21% -$222K 0.51% 26
2017
Q4
$925K Buy
+296,488
New +$925K 0.68% 26